NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Patients infected with hepatitis C virus (HCV) type 1 who have a slow response to pegylated interferon-alfa and ribavirin can benefit from continuing…
NEW YORK (Reuters Health) – The dose of misoprostol given after mifepristone for termination of early pregnancy should stay at the recommended dose rather than be lowered, a…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…
NEW YORK (Reuters Health) – Episodes of dyspnea are more common in patients treated with the antiplatelet agent than in those taking clopidogrel, although the clinical importance of…
NEW YORK (Reuters Health) – Cumulative exposure to particular antiretroviral agents in patients being treated for HIV infection is associated with an increased risk of developing chronic kidney…
NEW YORK (Reuters Health) – Among patients with metabolic syndrome and mixed dyslipidemia, treatment with fenofibric acid in combination with a statin reduces the prevalence of metabolic syndrome…
NEW YORK (Reuters Health) – Since the advantage of adding chemotherapy to surgical resection of early-stage non-small-cell lung cancer was demonstrated a few years ago, the strategy has…
NEW YORK (Reuters Health) – Statins may be overused in patients without cardiovascular disease, according to a report in Archives of Internal Medicine. The researchers pooled data from…
NEW YORK (Reuters Health) – Two reports today in two separate journals — a meta-analysis and a large retrospective study — provide more evidence linking the thiazolidinedione rosiglitazone…